Estimation and extrapolation of optimal treatment and testing strategies

We review recent developments in the estimation of an optimal treatment strategy or regime from longitudinal data collected in an observational study. We also propose novel methods for using the data obtained from an observational database in one health‐care system to determine the optimal treatment regime for biologically similar subjects in a second health‐care system when, for cultural, logistical, or financial reasons, the two health‐care systems differ (and will continue to differ) in the frequency of, and reasons for, both laboratory tests and physician visits. Finally, we propose a novel method for estimating the optimal timing of expensive and/or painful diagnostic or prognostic tests. Diagnostic or prognostic tests are only useful in so far as they help a physician to determine the optimal dosing strategy, by providing information on both the current health state and the prognosis of a patient because, in contrast to drug therapies, these tests have no direct causal effect on disease progression. Our new method explicitly incorporates this no direct effect restriction. Copyright © 2008 John Wiley & Sons, Ltd.

[1]  J. Robins,et al.  Recovery of Information and Adjustment for Dependent Censoring Using Surrogate Markers , 1992 .

[2]  J. Robins.  Correcting for non-compliance in randomized trials using structural nested mean models , 1994 .

[3]  J. Robins,et al.  Adjusting for Nonignorable Drop-Out Using Semiparametric Nonresponse Models , 1999 .

[4]  J. Robins,et al.  Sensitivity Analysis for Selection bias and unmeasured Confounding in missing Data and Causal inference models , 2000 .

[5]  James M. Robins,et al.  Marginal Structural Models versus Structural nested Models as Tools for Causal inference , 2000 .

[6]  Maria Deloria-Knoll,et al.  Survival Benefit of Initiating Antiretroviral Therapy in HIV-Infected Persons in Different CD4+ Cell Strata , 2003, Annals of Internal Medicine.

[7]  S. Murphy,et al.  Optimal dynamic treatment regimes , 2003 .

[8]  James M. Robins,et al.  Optimal Structural Nested Models for Optimal Sequential Decisions , 2004 .

[9]  F. Lert,et al.  Predictors identified for losses to follow-up among HIV-seropositive patients. , 2006, Journal of clinical epidemiology.

[10]  M. Petersen,et al.  Diagnosing Bias in the Inverse Probability of Treatment Weighted Estimator Resulting from Violation of Experimental Treatment Assignment , 2006 .

[11]  J. Robins,et al.  Comparison of dynamic treatment regimes via inverse probability weighting. , 2006, Basic & clinical pharmacology & toxicology.

[12]  M. J. Laan.  Causal Effect Models for Intention to Treat and Realistic Individualized Treatment Rules , 2006 .

[13]  Chunming ZhangFebruary.  Discussion of the Paper by \adjusting for Non-ignorable Drop-out Using Semiparametric Non-response Models" , 2007 .

[14]  Erica E M Moodie,et al.  Demystifying Optimal Dynamic Treatment Regimes , 2007, Biometrics.

[15]  J. Robins,et al.  Comment: Performance of Double-Robust Estimators When “Inverse Probability” Weights Are Highly Variable , 2007, 0804.2965.